72 related articles for article (PubMed ID: 31622526)
21. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
[TBL] [Abstract][Full Text] [Related]
22. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
23. Cervical koilocytosis and high risk HPV types: the benefit of laser vaporization.
Hørding U; Rygaard C; Ruge S; Felding C; Lundvall F; Junge J
Eur J Obstet Gynecol Reprod Biol; 1993 Oct; 51(2):125-30. PubMed ID: 8119458
[TBL] [Abstract][Full Text] [Related]
24. Transformation Zone Assessment Using Visual Inspection With Acetic Acid Before and After Thermal Ablation: Implications for Follow-Up.
Balli C; Kenfack B; Horo A; Jeronimo J; Abatsong E; Wisniak A; Vassilakos P; Petignat P
JCO Glob Oncol; 2023 Feb; 9():e2200241. PubMed ID: 36854076
[TBL] [Abstract][Full Text] [Related]
25. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
[TBL] [Abstract][Full Text] [Related]
27. A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial.
Basu P; Mwanahamuntu M; Pinder LF; Muwonge R; Lucas E; Nyambe N; Chisele S; Shibemba AL; Sauvaget C; Sankaranarayanan R; Prendiville W; Parham GP
Nat Med; 2024 Jun; ():. PubMed ID: 38918630
[TBL] [Abstract][Full Text] [Related]
28. Overview of thermal ablation devices for treating precancerous cervical lesions in low-resource settings.
Boles T; Salcedo MP; Lorenzoni C; Osman N; Baker E; Schmeler K; Carns J
J Glob Health; 2022 Dec; 12():03089. PubMed ID: 36579405
[No Abstract] [Full Text] [Related]
29. An appraisal of the meta-analysis on the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions.
Papoutsis D
Prev Med; 2019 Jun; 123():341-342. PubMed ID: 31122397
[No Abstract] [Full Text] [Related]
30. Analysis of the influence of psychological nursing on psychological status and satisfaction of patients with cervical precancerous lesions.
Yu Z; Ma X; Yang X; Xia M; Zhang Y; Gan L
Minerva Med; 2022 Oct; 113(5):881-883. PubMed ID: 33555162
[No Abstract] [Full Text] [Related]
31. [Not Available].
Berenice IM; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 Oct; ():. PubMed ID: 26601622
[No Abstract] [Full Text] [Related]
32. In Vivo Evaluation of Safety and Efficacy of Ethyl Cellulose-Ethanol Tissue Ablation in a Swine Cervix Model.
Quang TT; Yang J; Kaluzienski ML; Parrish A; Farooqui A; Katz D; Crouch B; Ramanujam N; Mueller JL
Bioengineering (Basel); 2023 Oct; 10(11):. PubMed ID: 38002370
[TBL] [Abstract][Full Text] [Related]
33. Locoregional Thermal and Chemical Tumor Ablation: Review of Clinical Applications and Potential Opportunities for Use in Low- and Middle-Income Countries.
Quang TT; Yang J; Mikhail AS; Wood BJ; Ramanujam N; Mueller JL
JCO Glob Oncol; 2023 Aug; 9():e2300155. PubMed ID: 37625104
[TBL] [Abstract][Full Text] [Related]
34. Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China.
Zou M; Liu H; Liu H; Wang M; Zou Z; Zhang L
Front Immunol; 2023; 14():1119566. PubMed ID: 37051255
[TBL] [Abstract][Full Text] [Related]
35. Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial.
Soler M; Alfaro K; Masch RJ; Conzuelo Rodriguez G; Qu X; Wu S; Sun J; Hernández Jovel DM; Bonilla J; Puentes LO; Murillo R; Alonzo TA; Felix JC; Castle P; Cremer M
JCO Glob Oncol; 2022 Dec; 8():e2200112. PubMed ID: 36525620
[TBL] [Abstract][Full Text] [Related]
36. Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis.
Piret EM; Payne BA; Smith LW; Trawin J; Orem J; Ogilvie G; Nakisige C
Fam Med Community Health; 2022 May; 10(2):. PubMed ID: 35523456
[TBL] [Abstract][Full Text] [Related]
37. Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
Metaxas T; Kenfack B; Sormani J; Tincho E; Lemoupa Makajio S; Wisniak A; Vassilakos P; Petignat P
BMC Cancer; 2022 Feb; 22(1):132. PubMed ID: 35109806
[TBL] [Abstract][Full Text] [Related]
38. A cross-sectional study exploring triage of human papillomavirus (HPV)-positive women by visual assessment, manual and computer-interpreted cytology, and HPV-16/18-45 genotyping in Cameroon.
Vassilakos P; Wisniak A; Catarino R; Tincho Foguem E; Balli C; Saiji E; Tille JC; Kenfack B; Petignat P
Int J Gynecol Cancer; 2021 Jun; 31(6):808-816. PubMed ID: 33833084
[TBL] [Abstract][Full Text] [Related]
39. Health Outcomes at 1 Year After Thermal Ablation for Cervical Precancer Among Human Papillomavirus- and Visual Inspection With Acetic Acid-Positive Women in Honduras.
Slavkovsky RC; Bansil P; Sandoval MA; Figueroa J; Rodriguez DM; Lobo JS; Jeronimo JA; de Sanjosé S
JCO Glob Oncol; 2020 Oct; 6():1565-1573. PubMed ID: 33074738
[TBL] [Abstract][Full Text] [Related]
40. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
